read on-line version | ISSN 2600-013X
   

Research and Innovation

16 September 2022

European Commission Logo
News-of-the-Day_1712

Follow us | EU Science & Innovation | EU Science & Innovation | EU Science & Innovation

News of the day
EU and CEPI to provide funding for the development of a vaccine against Rift Valley fever
Today, the Commission and the Coalition for Epidemic Preparedness Innovations (CEPI) are launching a new call for funding to advance the development of innovative vaccines against the viral disease, Rift Valley fever. €35 million in financial support will be provided by Horizon Europe, the EU’s research and innovation programme, and up to €50 million in total will be made available by CEPI to support promising Rift Valley fever vaccine candidates through Phase I and II clinical trials in endemic areas.

Mariya Gabriel, Commissioner for Innovation, Research, Culture, Education and Youth, said:

Rift Valley fever regularly leads to serious outbreaks and, with continuing climate change, could well spread in its sphere of influence. If we fail to act now, there is a risk that we could see more frequent and deadly Rift Valley fever outbreaks, with serious public health and socioeconomic consequences. Advancing globally accessible vaccines against Rift Valley fever for human use is an essential step within the One Health framework to ensure local pastoral communities affected by the disease, and the world, are better protected for the future.

Permalink
permalink Main URL
SeeAlso
See also Health research and innovation
The European Commission is committed to personal data protection. Any personal data is processed in line with the Regulation (EU) 2018/1725. Please read the privacy statement.

Stay up to date and subscribe to our newsletter | To unsubscribe or change your profile and selections please visit our web site.
The European Commission is committed to personal data protection. Any personal data is processed in line with the Regulation (EU) 2018/1725. Please read the privacy statement